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Streptomyces is a very important industrial bacterium, which 
produces two thirds of clinically relevant secondary metabolites. It 
is considered as a “multicellular” prokaryotic model that includes 
programmed cell death (PCD) and sporulation in solid cultures. 
Streptomyces industrial fermentations are mainly produced in liquid 
cultures (large bioreactors) conditions in which most species do 
not sporulate, and it was traditionally considered that there was no 
differentiation. It has been almost unanimously accepted that mycelial 
morphology in liquid fermentation was correlated with the production 
of secondary metabolites, albeit the cause-effect relationship was 
controversial: some authors hold that cellular aggregation, and 
hence pellet and clump formation is fundamental to obtaining good 
production of secondary metabolites. On the other hand, other authors 
state that there is no relationship between morphology and secondary 
metabolite production. In conclusion, there was no general consensus 
correlating morphology with secondary metabolite production, and the 
lack of a consistent developmental model in Streptomycetes hindered 
the precise description of reliable phenotypes to analyse and optimize 
industrial fermentations.
New drugs, especially antibiotics, are urgently required in clinic and 
the most propitious natural source remained in environmental bacteria, 
especially Streptomyces. The screening for new secondary metabolites 
was traditionally performed by means of strain isolations, cultures and 
bioassays [1], a process tremendously productive during the “Golden 
Age” of antibiotics (1940s–1960s), but which was becoming more 
and more difficult once the most common antibiotics were already 
discovered. The main handicap of this screening approach was the high 
number of false negatives: i.e. strains discarded as bioactive compound 
producers, because they did not reached the producing phase in the 
lab. At present, most research groups working in the search for new 
bioactive compounds are making it by means of metagenomics: 
large genome sequencing and identification of biosynthetic pathways 
by sequence homology. However, this genetic approach is totally 
dependent on a previous knowledge in order to find homologies, and it 
is not suitable to discover totally new bioactive compounds. 
The classical Streptomyces developmental model for confluent 
solid cultures assumed that differentiation processes took place 
along the transversal axis of the cultures (bottom-up): completely 
viable vegetative mycelia (substrate) grew on the surface and inside 
agar until they underwent a PCD, after which hyphae differentiated 
to a reproductive (aerial) mycelium characterized by the presence 
of hydrophobic covers, giving it a characteristic greyish appearance. 
Substrate and aerial mycelia were multinucleated, but at the end of 
the cycle, aerial hyphae formed septa and spore chains (Figure 1). In 
liquid cultures, most Streptomycetes did not sporulate, and it was 
assumed that there was no differentiation. This developmental model 
was refined in recent years, describing novel aspects during the pre 
sporulation phases in solid and liquid cultures [2]. The existence of 
a previously unidentified compartmentalized mycelium (MI) that 
initiates the developmental cycle after spore germination was described. 
The MI suffers a highly ordered cell death (PCD), and the remaining 
viable segments of this mycelium begin to enlarge as a multinucleated 
mycelium (MII). In solid cultures, two types of MII have been defined, 
based on the absence (in early development) or presence (in late 
development) of the hydrophobic layers characteristic of aerial hyphae. 
The traditionally denominated substrate mycelium corresponds to MII, 
lacking hydrophobic layers, and the aerial mycelium, to MII coated 
with these hydrophobic layers (Figure 1). The only mycelial phases 
present in liquid cultures were MI and MII without hydrophobic layers 
(Figure 1). In addition, it was demonstrated that MII is the antibiotic 
producer mycelium, being the first time than antibiotic production 
could be associated to differentiation in Streptomyces liquid cultures.
The new Streptomyces developmental cycle opens a new background 
in which study differentiation, and it will be the key for the analysis and 
optimization of hyphae differentiation in industrial fermentations [3]. 
In addition, finding new secondary metabolites is becoming critical in 
biomedicine, and the only way will be to resume screening from natural 
strains. Th e latest discoveries about Streptomyces differentiation will 
be crucial to design new experimental approaches to optimize the 
selection process, and reduce the incidence of false negatives.
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